Company: FRFXF
Filing Date: 2025-10-09
Form Type: F-10/A
Source: 0001104659-25-098335
Chunk: 3

Company: FAIRFAX FINANCIAL HOLDINGS LTD/ CAN
Filing Date: 2025-10-09
Form: F-10/A
Chunk 3
---
5 Exchange Offer, are referred to herein as the “ 2055 Notes. ” References herein to “Notes of a series” and similar expressions refer to either or both of (i) the 2035 Notes, and (ii) the 2055 Notes, as applicable, which are two separate series of debt securities of the Company. • You may withdraw your tender of the 2035 Initial Notes or the 2055 Initial Notes, as applicable, at any time before the expiration of the applicable Exchange Offer. (continued on next page)

TABLE OF CONTENTS

(continued from cover)

•

Each of the Exchange Offers will expire at 5:00 p.m., New York City time, on November 7, 2025, unless the Company extends either or both Exchange Offers, in which case, such Exchange Offer(s) will expire at 5:00 p.m., New York City time, on the date to which such Exchange Offer is extended (in each case, the “

#### Expiration Date
”).

#### The Exchange Notes
•

The terms of the Exchange Notes of each series to be issued in the applicable Exchange Offer will be substantially identical to the Initial Notes of such series except that, unlike the Initial Notes, the Exchange Notes will be freely tradable in the United States by persons not affiliated with us, will not bear legends restricting their transfer and will not contain the registration rights provisions of the Initial Notes.

•

The Exchange Notes will be issued in United States dollars.

•

The Exchange Notes will be issued in minimum denominations of $2,000 principal amount and integral multiples of $1,000 in excess thereof.

•

There is no market through which the Exchange Notes may be sold and purchasers may not be able to resell the Exchange Notes issued pursuant to the Exchange Offers. This may affect the pricing of the Exchange Notes in the secondary market, the transparency and availability of trading prices, the liquidity of the Exchange Notes, and the extent of regulation affecting the Company. See “Risk Factors” commencing on page 16.

Before participating in either of the Exchange Offers, please carefully read this short form prospectus, including the section entitled “Risk Factors” commencing on page 16.

For a more detailed description of the Exchange Notes, please refer to the sections in this short form prospectus entitled “Description of the Notes” commencing on page 67.

The Exchange Offers are being made by the Company, which is a foreign issuer in the United States and is permitted, under a multijurisdiction